Xcelience Targets Formulation Development
The former formulation-development business of MDS Pharma Services seeks to build its niche in early-phase drug development.
Rocky Outlook for Pharmaceuticals
Financial experts share their insights for the performance for innovator drug companies and generic-drug players.
Outsourcing Outlook: API Manufacturers Go From Grams to Tonnes
CMOs have positive outlook for 2008 but are wary of competitive pressures.
